BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 16315361)

  • 1. Using honey to heal a chronic wound in a patient with epidermolysis bullosa.
    Hon J
    Br J Nurs; 2005 Oct 27-Nov 9; 14(19):S4-5, S8, S10 passim. PubMed ID: 16315361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using honey to heal a chronic wound in a patient with epidermolysis bullosa.
    Hon J
    Br J Nurs; 2005 Oct; 14(19 Suppl):S4-S12. PubMed ID: 16301920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a keratin-based hydrogel in the management of recessive dystrophic epidermolysis bullosa.
    Than MP; Smith RA; Cassidy S; Kelly R; Marsh C; Maderal A; Kirsner RS
    J Dermatolog Treat; 2013 Aug; 24(4):290-1. PubMed ID: 22208480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wound management for children with epidermolysis bullosa.
    Denyer JE
    Dermatol Clin; 2010 Apr; 28(2):257-64, viii-ix. PubMed ID: 20447488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of trimethoprim in wound healing of patients with epidermolysis bullosa: a feasibility trial.
    Lara-Corrales I; Parkin PC; Stephens D; Hamilton J; Koren G; Weinstein M; Sibbald RG; Pope E
    J Am Acad Dermatol; 2012 Feb; 66(2):264-70. PubMed ID: 22153787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic granulocyte colony-stimulating factor (G-CSF) enhances wound healing in dystrophic epidermolysis bullosa (DEB): Results of a pilot trial.
    Fine JD; Manes B; Frangoul H
    J Am Acad Dermatol; 2015 Jul; 73(1):56-61. PubMed ID: 25956659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of a keratin-based wound dressing in the management of wounds in a patient with recessive dystrophic epidermolysis bullosa.
    Kirsner RS; Cassidy S; Marsh C; Vivas A; Kelly RJ
    Adv Skin Wound Care; 2012 Sep; 25(9):400-3. PubMed ID: 22914035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wound closure by secondary intention is successful in the treatment of squamous cell carcinomas in recessive dystrophic epidermolysis bullosa.
    Rodríguez-Lojo R; Fernández-Jorge B; DE Andrés A; Peña C; García-Silva J
    Eur J Dermatol; 2011; 21(2):302-3. PubMed ID: 21540143
    [No Abstract]   [Full Text] [Related]  

  • 9. Using Urgotul dressing for the management of epidermolysis bullosa skin lesions.
    Blanchet-Bardon C; Bohbot S
    J Wound Care; 2005 Nov; 14(10):490-1, 494-6. PubMed ID: 16304926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of cutaneous pinch grafts in the healing of patients with dystrophic epidermolysis bullosa wounds: report of four cases].
    Claude O; Binder JP; Bustamante K; Blanchet-Bardon C; Andrivon F; Revol M; Servant JM
    Ann Chir Plast Esthet; 2005 Jun; 50(3):189-96. PubMed ID: 15963838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purified type I collagen wound matrix improves chronic wound healing in patients with recessive dystrophic epidermolysis bullosa.
    Gorell ES; Leung TH; Khuu P; Lane AT
    Pediatr Dermatol; 2015; 32(2):220-5. PubMed ID: 25557742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evidence supporting the use of honey as a wound dressing.
    Molan PC
    Int J Low Extrem Wounds; 2006 Mar; 5(1):40-54. PubMed ID: 16543212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study between honey and povidone iodine as dressing solution for Wagner type II diabetic foot ulcers.
    Shukrimi A; Sulaiman AR; Halim AY; Azril A
    Med J Malaysia; 2008 Mar; 63(1):44-6. PubMed ID: 18935732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Participatory co-design of patient-reported outcome indicators and N-of-1 evaluation of a dressing glove for Epidermolysis bullosa.
    Graham T; Sooriah S; Box R; Gage H; Williams P; Clemett V; Grocott P
    J Wound Care; 2020 Dec; 29(12):751-762. PubMed ID: 33320744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy of biocellulose, carboxymethyl cellulose and normal saline dressing in epidermolysis bullosa.
    Dwiyana RF; Yogya Y; Gondokaryono SP; Diana IA; Suwarsa O; Ramali LM; Sutedja EK; Rahardja JI; Gunawan H
    J Wound Care; 2019 Oct; 28(Sup10):S4-S9. PubMed ID: 31600103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered expression of L-arginine metabolism pathway genes in chronic wounds in recessive dystrophic epidermolysis bullosa.
    Wessagowit V; Mallipeddi R; McGrath JA; South AP
    Clin Exp Dermatol; 2004 Nov; 29(6):664-8. PubMed ID: 15550148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dystrophic calcinosis cutis in autosomal recessive dystrophic epidermolysis bullosa.
    Bhari N; Bharti P
    BMJ Case Rep; 2019 Sep; 12(9):. PubMed ID: 31540927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oleogel-S10 in Dystrophic Epidermolysis Bullosa: A Case Series Evaluating the Impact on Wound Burden Over Two Years.
    Torres Pradilla M; Álvarez E; Novoa M; Lozano I; Trujillo M
    Adv Ther; 2024 Feb; 41(2):867-877. PubMed ID: 38170434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amnia for intractable skin ulcers with recessive dystrophic epidermolysis bullosa: report of three cases.
    Hasegawa T; Mizoguchi M; Haruna K; Mizuno Y; Muramatsu S; Suga Y; Ogawa H; Ikeda S
    J Dermatol; 2007 May; 34(5):328-32. PubMed ID: 17408442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thalidomide in the management of epidermolysis bullosa pruriginosa.
    Ozanic Bulic S; Fassihi H; Mellerio JE; McGrath JA; Atherton DJ
    Br J Dermatol; 2005 Jun; 152(6):1332-4. PubMed ID: 15949003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.